AVADEL PHARMACEUTICALS PLC (AVDLXXXX)
Institutional ownership reported to the SEC as of Q2 2026, across 31 quarters.
1
Reporting holders
$16
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| HUNTINGTON NATIONAL BANK | $16 | 1 | 0.00% | 15q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $16 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $16 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 2 | $12.9M | 600,001 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 3 | $11.3M | 737,501 | 0 | 0 | 0 | 0.0% |
| Q2 2025 | 4 | $6.7M | 737,501 | 1 | 0 | 0 | 3.2% |
| Q1 2025 | 3 | $5.8M | 737,501 | 0 | 0 | 0 | 0.0% |
| Q4 2024 | 3 | $7.7M | 737,001 | 0 | 0 | 0 | 0.0% |
| Q3 2024 | 4 | $9.7M | 738,001 | 0 | 0 | 0 | 0.0% |
| Q2 2024 | 8 | $94.1M | 6,691,915 | 2 | 0 | 1 | 0.0% |
| Q1 2024 | 113 | $1.2B | 68,202,583 | 29 | 36 | 27 | 5.7% |
| Q4 2023 | 105 | $812.6M | 56,109,224 | 14 | 29 | 27 | 2.5% |
| Q3 2023 | 93 | $562.0M | 53,243,622 | 14 | 31 | 25 | 2.6% |
| Q2 2023 | 92 | $882.8M | 50,857,468 | 22 | 31 | 22 | 5.1% |
| Q1 2023 | 84 | $450.5M | 47,303,759 | 15 | 32 | 15 | 4.4% |
| Q4 2022 | 77 | $230.2M | 29,451,432 | 20 | 18 | 16 | 10.3% |
| Q3 2022 | 80 | $172.5M | 31,383,096 | 14 | 20 | 17 | 8.8% |
| Q2 2022 | 82 | $87.6M | 33,737,776 | 17 | 23 | 19 | 6.0% |
| Q1 2022 | 83 | $252.6M | 35,806,314 | 17 | 19 | 25 | 3.2% |
| Q4 2021 | 84 | $297.0M | 35,155,382 | 11 | 24 | 20 | 4.4% |
| Q3 2021 | 86 | $332.3M | 32,066,852 | 10 | 25 | 22 | 5.4% |
| Q2 2021 | 84 | $227.5M | 32,560,629 | 12 | 24 | 17 | 3.7% |
| Q1 2021 | 80 | $305.1M | 32,638,877 | 11 | 24 | 23 | 3.5% |
| Q4 2020 | 82 | $218.5M | 32,243,308 | 20 | 21 | 19 | 1.4% |
| Q3 2020 | 81 | $160.8M | 31,489,622 | 16 | 24 | 16 | 1.3% |
| Q2 2020 | 84 | $305.1M | 36,333,156 | 29 | 26 | 11 | 3.8% |
| Q1 2020 | 67 | $244.5M | 26,859,024 | 34 | 7 | 17 | 13.6% |
| Q4 2019 | 43 | $144.5M | 18,427,991 | 12 | 11 | 7 | 3.7% |
| Q3 2019 | 43 | $81.5M | 19,370,499 | 9 | 7 | 10 | 1.1% |
| Q2 2019 | 41 | $56.6M | 19,544,759 | 8 | 11 | 9 | 0.2% |
| Q1 2019 | 43 | $28.2M | 19,608,780 | 2 | 8 | 15 | 0.0% |
| Q4 2018 | 53 | $51.2M | 19,837,756 | 1 | 0 | 2 | 0.1% |